BlossomHill Therapeutics logo

BlossomHill Therapeutics

Website

Team & Investors

Leadership, board of directors, and investment partners

Executives
0
Board Members
0
Investors
10
Total Funding
$257.1M
Investors
10 investors across all rounds
BC
BioTrack Capital
BC
Brahma Capital (Texas)
CV
Colt Ventures
CA
Cormorant Asset Management
VENTURE_CAPITAL
HD
H&D Asset Management

+5 more investors

Sign in to view all

Explore More Data
Detailed analysis for BlossomHill Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

BlossomHill Therapeutics Leadership & Investors

BlossomHill Therapeutics is led by a team of experienced leaders. The company has attracted investment from 10 institutional and strategic investors.

Who Has Invested in BlossomHill Therapeutics?

BlossomHill Therapeutics has raised $257.1M from 10 investors including venture capital firms, private equity investors, and strategic partners.

Investment Opportunity

Accredited investors can access BlossomHill Therapeutics shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.